Navigation Links
Jazz Pharmaceuticals Announces Second Quarter 2014 Financial Results And Updated Guidance
Date:8/5/2014

DUBLIN, Aug. 5, 2014 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the second quarter ended June 30, 2014 and updated financial guidance for 2014.

"Strong underlying demand for our products and the start of our European Union launch of Defitelio led to significant revenue growth in the second quarter," said Bruce C. Cozadd, chairman and chief executive officer of Jazz Pharmaceuticals plc. "We have successfully completed three transactions in 2014, including our recently announced acquisition of the rights to defibrotide in the Americas. With an expanding clinical development pipeline targeted in the sleep and hematology/oncology therapeutic areas and our continued focus on business development, we believe that we are poised to provide significant financial growth in 2014 and beyond."

Adjusted net income attributable to Jazz Pharmaceuticals plc for the second quarter of 2014 was $127.8 million, or $2.05 per diluted share, compared to $88.3 million, or $1.43 per diluted share, for the second quarter of 2013.

GAAP net income attributable to Jazz Pharmaceuticals plc for the second quarter of 2014 was $43.7 million, or $0.70 per diluted share, compared to $42.2 million, or $0.69 per diluted share, for the second quarter of 2013. GAAP net income attributable to Jazz Pharmaceuticals plc for the second quarter of 2014 included a non-cash intangible asset impairment charge of $32.8 million. Reconciliations of applicable GAAP reported to non-GAAP adjusted information are included in this press release.

Second Quarter 2014 Revenues and Product SalesTotal revenues for the second quarter of 2014 were $291.2 million, an increase of 40% over total revenues of $208.3 million for the second quarter of 2013. This increase was driven primarily by net product sales of Xyrem® (sodium oxybate) oral
'/>"/>

SOURCE Jazz Pharmaceuticals plc
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine technology :

1. Cumberland Pharmaceuticals Reports Second Quarter 2014 Financial Results
2. Avanir Pharmaceuticals to Participate in Two Conferences in August
3. Heritage Pharmaceuticals Inc. Signs Exclusive Development Supply & Distribution Agreement with Dexcel Ltd.
4. Genoa Pharmaceuticals Receives Orphan-Drug Designation for Pirfenidone in the Inhaled Treatment of Idiopathic Pulmonary Fibrosis (IPF)
5. Jazz Pharmaceuticals Announces Participation at Canaccord Genuity Conference on August 13
6. Lemelson Capital Management Further Increases Short Position in Ligand Pharmaceuticals (NASDAQ: LGND), Updates LGND Research Report with New Material Information
7. Rock Creek Pharmaceuticals to Present at the Annual BioPharm America International Partnering Conference
8. Pharmaceuticals Learning the Language of the New Healthcare Landscape
9. Valeant Pharmaceuticals And Pershing Square Respond To Frivolous Allergan Lawsuit
10. Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy
11. Inovio Pharmaceuticals to Host Second Quarter 2014 Financial Results Call on August 11, 2014
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2015)... 25, 2015  With the introduction of Elekta,s new ... radiosurgery are now available for more patients with a ... generation stereotactic radiosurgery system for the brain, integrates advanced ... the versatility of Gamma Knife radiosurgery. Elekta unveiled Leksell ... ESTRO Forum in Barcelona . ...
(Date:4/24/2015)... Today, humanity takes a massive step toward reaching ... cronuts: 1-800 CONTACTS announces their new Apple Watch app which ... Two taps. New contacts. From your watch. ... also features LensGauge which helps keep track of how long ... reorder. "Since our inception, we,ve been dedicated to ...
(Date:4/24/2015)... , April 24, 2015  Perrigo Company plc ... its rejection of the unsolicited offer from Mylan NV ... the outstanding shares of Perrigo for $60.00 per share ... ordinary Perrigo share (the "Offer").  The ... per share significantly undervalued the Company and its future ...
Breaking Medicine Technology:New Leksell Gamma Knife to benefit more patients with brain disease 2New Leksell Gamma Knife to benefit more patients with brain disease 3Attention: We live in the future. Order contact lenses from your wrist with the 1-800 CONTACTS app for Apple Watch 2Perrigo Rejects Mylan Unsolicited Offer 2Perrigo Rejects Mylan Unsolicited Offer 3Perrigo Rejects Mylan Unsolicited Offer 4
... The Barbara Ann Karmanos Cancer Institute announced today that its spin-off ... capital to start the commercialization process of SoftVue, an alternative to mammography. ... (Logo:   http://www.newscom.com/cgi-bin/prnh/20071106/KARMANOSLOGO ) , ... SoftVue is a tomographic ultrasound imaging and ...
... 24 Genzyme Corp. has signed a consent decree agreeing to correct manufacturing ... to the federal government $175 million in unlawful profits from the sale ... announced today. , , , ... , , ...
Cached Medicine Technology:Karmanos Cancer Institute's Delphinus Receives $8 Million in Venture Capital for Product Development of Breast Cancer Imaging Tool 2Karmanos Cancer Institute's Delphinus Receives $8 Million in Venture Capital for Product Development of Breast Cancer Imaging Tool 3Karmanos Cancer Institute's Delphinus Receives $8 Million in Venture Capital for Product Development of Breast Cancer Imaging Tool 4Karmanos Cancer Institute's Delphinus Receives $8 Million in Venture Capital for Product Development of Breast Cancer Imaging Tool 5Genzyme Corp. Signs Consent Decree to Correct Violations at Allston, Mass., Manufacturing Plant and Give up $175 Million in Profits 2Genzyme Corp. Signs Consent Decree to Correct Violations at Allston, Mass., Manufacturing Plant and Give up $175 Million in Profits 3
(Date:4/27/2015)... Attorney Dan Newlin, of the Law Offices of ... took that commitment to a whole new level with the ... easier for existing and potential clients to contact the law ... added value to the firm’s services, #Dan covers Central Florida, ... law offices. , “I knew the pound sign (#) could ...
(Date:4/27/2015)... Texas has saved $433 million by converting their ... drug offenders with addiction treatment, according to an article ... states, including Massachusetts, are considering adopting justice reinvestment policies ... community recovery programs to help redress rampant addiction among ... Governments WA, ID, NE, KS, MI, PA, WV, ...
(Date:4/27/2015)... (PRWEB) April 27, 2015 Climate change ... accuracy depends on the number of variables used and ... two noted scientists, water researcher Gerald Pollack, PhD, and ... Hour™ Power of Water® radio show, noted three potential ... , None of these individuals dispute that Earth’s ...
(Date:4/27/2015)... NZ (PRWEB) April 27, 2015 ... enhancement to their suite of mobile speech productivity ... and iOS tablets and smartphones. , ... Mobile Operating System since 2005. With the ... Winscribe’s fourth generation mobile application interface in the ...
(Date:4/27/2015)... 2015 PREVENT Life Safety, America’s premier ... operations with the addition of an account manager in ... to a growing customer base, Curtis Rice, an experienced ... Senior Account Manager. Curtis has been added to the ... throughout the Houston area and beyond. , ...
Breaking Medicine News(10 mins):Health News:Dan Newlin Hashtags It With #Dan 2Health News:Texas Saves $443 Million Embracing Justice Reinvestment for Drug Charges 2Health News:Texas Saves $443 Million Embracing Justice Reinvestment for Drug Charges 3Health News:Global warming: Computer weather models flawed report Climatologist, Water Researcher on Sharon Kleyne Hour™ radio show 2Health News:Global warming: Computer weather models flawed report Climatologist, Water Researcher on Sharon Kleyne Hour™ radio show 3Health News:Winscribe Professional Dictation for Smartphones Evolves as Microsoft’s Mobile OS Grows 2Health News:Winscribe Professional Dictation for Smartphones Evolves as Microsoft’s Mobile OS Grows 3Health News:Winscribe Professional Dictation for Smartphones Evolves as Microsoft’s Mobile OS Grows 4Health News:PREVENT Life Safety Services Welcomes Curtis Rice as a New Senior Account Manager in Houston, TX 2
... participated in the Flexidesc project by specifying a furnishing concept ... to devise a home that is accessible and adapted to ... having to move out of their homes owing to physical ... with the company SELLEX and the Matia Institute for Gerontology ...
... inflammatory bowel disease (IBD) and other gastrointestinal (GI) disorders ... according to a new study in Clinical Gastroenterology ... Gastroenterological Association. "Our results show that significant ... paralleled the increased use of computed tomography imaging," said ...
... -- Doctors may fail to detect precancerous growths if ... a new study warns. On the day before ... food and to consume only clear liquids. They also ... previous research suggests that up to one-quarter of colonoscopy ...
... 2012)Beatrice Mintz, Ph.D., professor and Jack Schultz chair in basic ... the Ninth Annual AACR Award for Lifetime Achievement in Cancer ... 2012, held Sunday, April 1, at 8:15 a.m. CT in ... for Lifetime Achievement in Cancer Research was established in 2004 ...
... Although eight states boosted their sales taxes on cigarettes over ... of such increases by states compared to 2009, a new ... shows. One thing that smoking prevention experts know from ... go up, the CDC said. "Increasing cigarette excise ...
... NEW YORK, N.Y. Autism Speaks, the world,s leading autism ... and appointed leaders to immediately develop a new, coordinated strategy ... autism epidemic in the wake of a new report ... autism is now diagnosed in a staggering 1 in every ...
Cached Medicine News:Health News:Tecnalia develops a flexible system for resting for people with reduced mobility 2Health News:Patients with digestive disorders may receive high levels of X-ray radiation 2Health News:Inadequate Bowel Prep May Invalidate Colonoscopy 2Health News:Beatrice Mintz, Ph.D., receives ninth annual AACR Award for Lifetime Achievement in Cancer Research 2Health News:Beatrice Mintz, Ph.D., receives ninth annual AACR Award for Lifetime Achievement in Cancer Research 3Health News:States' Efforts to Boost Cigarette Taxes Slows: CDC 2Health News:Autism Speaks demands urgent response to the autism epidemic in new CDC prevalence estimates 2Health News:Autism Speaks demands urgent response to the autism epidemic in new CDC prevalence estimates 3
... Studies have proven that the management of ... blood glucose levels is the most effective way ... comprehensive care aimed at maintaining or improving a ... complex and costly. , ,These have been ...
... requires making decisions about insulin dosages and ... decisions are guided by data from blood ... by the patterns that can be seen ... when the data is presented in organized ...
... Pumped Green Photocoagulator - Portable and rugged ... outpatient clinic, and operating room. Built to ... in the most demanding environments, the Novus ... A full line of accessories for ...
The ring maintains the bag tension avoiding the development of posterior capsule pleats. It is also established to compensate the efforts induced during the bag retraction....
Medicine Products: